1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2020 - Canada

Healthcare Analysis & Statistics 2020 - Canada

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

data types

1-17 of 17 reports

Impetigo - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 45 pages

Impetigo - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Impetigo – Pipeline Review, H1 2020, provides an overview of the Impetigo (Infectious Disease) ...

  • Anti-Infective
  • Healthcare
  • Canada
  • Product Initiative
  • Ferrer International SA

Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 35 pages

Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020, provides an overview ...

  • Blood Disease
  • Compression Therapy
  • Healthcare
  • Canada
  • Product Initiative

Myocarditis - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 48 pages

Myocarditis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H1 2020, provides an overview of the Myocarditis (Cardiovascular) ...

  • Healthcare
  • Canada
  • United States
  • Product Initiative
  • Evotec AG

Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 49 pages

Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019 Summary Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic recepto ...

  • Healthcare
  • Canada
  • Europe
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.

Impetigo - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 44 pages

Impetigo - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H2 2019, provides an overview of the Impetigo (Infectious Disease) ...

  • Anti-Infective
  • Healthcare
  • Canada
  • Product Initiative
  • Ferrer International SA

Cancer Pain - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 148 pages

Cancer Pain - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Pipeline Review, H2 2019, provides an overview of the Cancer Pain (Central ...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Canada
  • Product Initiative

Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 34 pages

Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2019, provides an overview ...

  • Blood Disease
  • Compression Therapy
  • Healthcare
  • Canada
  • Product Initiative

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 48 pages

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2018 Summary Carbonic ...

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Canada
  • Product Initiative

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 62 pages

Glucosylceramidase (Acid Beta Glucosidase or Alglucerase or D Glucosyl N Acylsphingosine Glucohydrolase or Beta Glucocerebrosidase or Imiglucerase or GBA or EC 3.2.1.45) - Pipeline Review, H2 2018 Su ...

  • Healthcare
  • Psychotic Disorder
  • Therapy
  • Canada
  • Protalix BioTherapeutics, Inc.

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 58 pages

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H2 ...

  • Eye Disease
  • Healthcare
  • Hospital
  • Canada
  • Novartis AG

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H1 2018

  • $ 3500
  • April 2018
  • 59 pages

Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen or Skin Fibroblast Elastase or Enkephalinase or CD10 or MME or EC 3.4.24.11) - Pipeline Review, H1 ...

  • Healthcare
  • Therapy
  • Canada
  • Product Initiative
  • Novartis AG

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H2 2017

  • $ 3500
  • July 2017
  • 51 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H2 2017 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) pipeline Target constitutes close to 6 molecules. ...

  • Autoimmune Disease
  • Healthcare
  • Therapy
  • Canada
  • Takeda Pharmaceutical Company Limited

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

  • $ 1500
  • August 2016
  • 38 pages

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016’, provides an overview of the Circassia ...

  • Healthcare
  • Medical Biotechnology
  • Canada
  • Company Operations
  • Circassia Pharmaceuticals plc

Perennial Allergic Rhinitis - Pipeline Review, H2 2016

  • $ 2000
  • August 2016
  • 51 pages

Perennial Allergic Rhinitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2016’, provides an overview of the Perennial Allergic ...

  • Allergy Drug
  • Healthcare
  • Therapy
  • Canada
  • Pfizer Inc.

Seasonal Allergic Rhinitis - Pipeline Review, H2 2016

  • $ 2000
  • August 2016
  • 49 pages

Seasonal Allergic Rhinitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Seasonal Allergic Rhinitis - Pipeline Review, H2 2016’, provides an overview of the Seasonal Allergic Rhinitis ...

  • Allergy Drug
  • Healthcare
  • Pharmaceutical
  • Canada
  • Pfizer Inc.

Immunovaccine, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • July 2016
  • 40 pages

Immunovaccine, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Immunovaccine, Inc. - Product Pipeline Review - 2016’, provides an overview of the Immunovaccine, Inc.’s ...

  • Healthcare
  • Immunotherapy
  • Vaccine
  • Canada
  • Immunovaccine Inc.

Perennial Allergic Rhinitis - Pipeline Review, H1 2016

  • $ 2000
  • March 2016
  • 59 pages

Perennial Allergic Rhinitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H1 2016’, provides an overview of the Perennial Allergic ...

  • Allergy Drug
  • Healthcare
  • Therapy
  • Canada
  • Pfizer Inc.



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on